125
Participants
Start Date
October 24, 2022
Primary Completion Date
September 1, 2026
Study Completion Date
December 31, 2027
Active tDCS
The study intervention will be participants self-applying 40 tDCS active stimulations with in-person supervision provided by trained study personnel. The self-applied intervention will continue 5 times per week over eight consecutive weeks. Treatment will occur in the home.
Sham tDCS
In this arm of the study participants will self-apply 40 sham tDCS stimulations with in-person supervision provided by trained study personnel. The self-applied intervention will continue 5 times per week over eight consecutive weeks. Treatment will occur in the home.
RECRUITING
The Rogosin Institute, New York
RECRUITING
NewYork-Presbyterian - Weill Cornell Medicine, New York
Collaborators (1)
Metropolitan Jewish Health System
OTHER
Rogosin Institute
UNKNOWN
Cornell University
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Weill Medical College of Cornell University
OTHER